Nurse Practitioner, Family · San Antonio, TX
NPI
1902355977
Since 2016
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
5107 Medical Dr
San Antonio, TX, 78229
Phone (210) 614-8612
Groups this clinician bills Medicare through
Medicare paid, 2023
$1,995
25 services
Medicare patients, 2023
12
Average age 70
Drug cost, 2024
$4.2M
7,018 prescriptions
Company payments, 2025
$4,660
From 34 companies
Medicare prescription drug claims, 2024
In 2024, the drug Diana V Huckaby prescribed most often to Medicare patients was Levothyroxine Sodium, with 534 prescriptions and refills. In total Diana V Huckaby wrote 7,018 Medicare prescriptions that cost $4.2M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-08-24.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Levothyroxine Sodium Generic | 534 | 1,478 | 236 | $5,881 |
| Ozempic Semaglutide | 506 | 838 | 166 | $802K |
| Mounjaro Tirzepatide | 443 | 527 | 122 | $555K |
| Atorvastatin Calcium Generic | 376 | 1,101 | 182 | $3,413 |
| Metformin Hcl Generic | 252 | 713 | 124 | $2,070 |
| Jardiance Empagliflozin | 243 | 578 | 105 | $336K |
| Rosuvastatin Calcium Generic | 228 | 643 | 113 | $4,140 |
| Metformin Hcl Er Metformin Hcl | 183 | 528 | 90 | $2,202 |
| Lisinopril Generic | 176 | 498 | 79 | $1,032 |
| Losartan Potassium Generic | 159 | 426 | 76 | $1,828 |
| Farxiga Dapagliflozin Propanediol | 156 | 346 | 58 | $192K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 149 | 396 | 90 | $18K |
| Trulicity Dulaglutide | 139 | 254 | 58 | $250K |
| Amlodipine Besylate Generic | 138 | 393 | 61 | $829 |
| Ezetimibe Generic | 119 | 319 | 55 | $3,197 |
Brand drugs: 3,245 claims; generic drugs: 3,121 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Diana V Huckaby $4,660 ($4,660 in general payments such as food, travel and fees) from 34 companies. The largest payer was Lilly USA, LLC with $422.
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC LLY | 23 | $422 |
| Novo Nordisk Inc NVO | 20 | $392 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 20 | $360 |
| Ascensia Diabetes Care Us Inc. | 34 | $328 |
| Amgen Inc. AMGN | 20 | $287 |
| Sequel Med Tech, LLC | 35 | $269 |
| Corcept Therapeutics CORT | 12 | $254 |
| Kyowa Kirin, Inc. 4151.T | 10 | $237 |
| Mannkind Corporation MNKD | 17 | $211 |
| Abbott Laboratories ABT | 13 | $191 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.